Recent Updates
Recently added Catalysts

Palo Alto Investors LP

Track Palo Alto Investors LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 51. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
BNTX
BNTX
BIONTECH SE-ADR
19.61 K
1.74 M
0.3
TSHA
TSHA
TAYSHA GENE THERAPIES INC
1.39 M
6.22 M
1
ACRS
ACRS
ACLARIS THERAPEUTICS INC
1.61 M
6.05 M
0.9
DNLI
DNLI
DENALI THERAPEUTICS INC
234.58 K
4.50 M
0.7
XENE
XENE
XENON PHARMACEUTICALS INC
51.34 K
2.98 M
0.5
ORKA
ORKA
ORUKA THERAPEUTICS INC
59.98 K
2.94 M
0.4
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 653.84 M

Holdings

51

Period

Q1 2026

Holdings in Top 20

85.6 %

QoQ Changes

-8.98 %

Top 20 Holdings